Most undervalued biotech across all markets?, page-60

BIT recalled my MEMO of AVX which was exactly the same as BIT.. They kept released the good announcements to the market of their Human trials. Their drug was working so well with HIV patients and they could not detect Viral Load from Patients after trials.. Then they announced for CR.. Investors bought huge including myself. After 1 months of CR,, they announced all the test will stop.. Terminated without proper explanation. ..Share Prices dropped from 12c to 1 c in 5 mins when market reopened. Everyone got screwed badly.. Never recovered the lost.. So that is the lesson of small drugs companies... very potential if they success but other way round,, we can lost everything.. Think, BIT will pull back more until they can announced more solid results and JV outcome. No down ramp..